Change in the Management of Neurotune AG
Neurotune AG announced a change in the management. Starting March 1st 2009, Dr. Bruno Oesch will take over the position of Chief Executive Officer from Dr. Andreas J. Schulze, who joined Neurotune in 2005 and is holding the position of CEO since 2006. Andreas J. Schulze will leave at his request to take on a fresh challenge in another company shortly.
Bruno Oesch is co-founder of Prionics AG and Neurotune AG. Serving as Chairman of the Board of Directors since Neurotune's foundation in 2005 he has been significantly involved in the strategic alignment of the company.
Most read news
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Hermann_von_Helmholtz
Researchers create 'leukemia in a dish' to better study it

Circular RNA makes fruit flies live longer - One step closer to the mysterious circRNAs

Accreditation to an International Standard - IS015189
Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
Stanford University Licenses Ingenuity Pathways Analysis, Collaborates on Systems Biology Solutions - Stanford Genome Technology Center Will apply Ingenuity's technology to More Quickly and Comprehensively Understand the Biology Underlying Their Experimental Datasets
